Factors Associated With E-Cigarette Quitting Behavior Among Adolescents in the United States: A Prospective Observational Study
Abstract
Purpose: This prospective observational study examined the association of socioecological factors with quitting behavior among US adolescents who exclusively use electronic cigarettes (e-cigarettes). Methods: We used data from past 30-day adolescent exclusive e-cigarette users (n = 243) participating in Wave 3 of the Population Assessment of Tobacco and Health study, who were then followed-up with approximately 12 months later for Wave 4. Weighted unadjusted and adjusted multivariate logistic regression models and structural equation modeling were performed to analyze the data. Results: Adolescents were significantly less likely to quit e-cigarettes if they perceived that nicotine in e-cigarettes was “slightly/somewhat harmful” to health (adjusted odds ratio [aOR] = 0.38; 95% confidence interval [CI]: 0.16–0.90, p = .02). Similarly, adolescents who reported that someone else in their home owned an e-cigarette (aOR = 0.43 [95% CI: 0.19–0.94], p = .03) or important people in their life used e-cigarettes (aOR = 0.45 [95% CI: 0.21–0.95], p = .03) were significantly less likely to quit e-cigarettes. The structural equation modeling showed a direct significant relationship of individual-level (b = 0.206, p = .02) and interpersonal-level factors (b = 0.170, p = .04) with e-cigarette quitting behavior. Discussion: Our findings suggest that individual-level (harm perception) and interpersonal-level (e-cigarette use at home and by important people) factors may play a significant role in e-cigarette quitting behavior among US adolescents.
Publication Title
Journal of Adolescent Health
Recommended Citation
Ahuja, N., Kedia, S., Jiang, Y., Xie, L., Ward, K., Pichon, L., Dillon, P., & Yu, X. (2022). Factors Associated With E-Cigarette Quitting Behavior Among Adolescents in the United States: A Prospective Observational Study. Journal of Adolescent Health, 71 (6), 729-736. https://doi.org/10.1016/j.jadohealth.2022.07.001